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Research on topics like 
heart arrhythmia, cancer, 
and disease caused by 
West Nile, Zika and influenza 
viruses may seem like tasks 
for scientists at a medical 
school. But important 
breakthroughs in medicine 
begin with basic research 
that happens in cell culture 
and in animal models.
Understanding and 
improving human health is 
just one area in which Utah 
State University faculty are 
at work with support from the 
Utah Agricultural Experiment 
Station. The discoveries they 
make have had far-reaching 
impacts, and we are 
increasingly focused on the 
many vital connections between the health of ecosystems, animals and people.
In this issue of Utah Science are stories of how goats may be important to 
understanding the most common type of heart disease, how your physiology 
may have a lot to do with bacteria in your gut, and how a team of our 
researchers have played a role in providing the world with medicines and 
vaccines and are at work to counter emerging diseases caused by Zika and 
other viruses.
This fall, the Utah Agricultural Experiment Station and USU’s College of 
Agriculture and Applied Sciences hosts an international conference that will 
bring together experts in large animal genetic engineering. These specialized 
animal models are important in work that may improve livestock production 
and also help humans hold cancer at bay, allow people with cystic fibrosis to 
breathe freely, or lead to treatments for neurological damage.
Our faculty are also organizing a second Utah One Health Symposium 
to focus on the interrelationships of animal health, human health and the 
environment. Understanding human, environmental and animal health are 
not distinct and separate undertakings. We are proud of the work our faculty 
and students do on research farms and in labs and classrooms, all aimed at 
improving lives.
Ken White
Director, Utah Agricultural Experiment Station
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Small, everyday decisions such as what to put in your grocery cart or which restaurant to eat 
at may seem insignificant. But in re-
ality, what’s on your plate and what’s 
missing from your plate could have 
more long-term health consequences 
than previously thought. The Applied 
Nutrition Research Group, a team of 
researchers in Utah State University’s 
College of Agricultural and Applied 
Sciences with a diverse range of 
expertise, is examining certain health 
concerns and how they relate to diet. 
Utah Agricultural Experiment Station 
researcher and Utah State University 
Associate Professor Abby Benning-
hoff and her team are specifically ex-
amining how the food we eat impacts 
the rate and severity of colon cancer. 
Scientists have long been inter-
ested in studying cancer. Ideally, they 
would be able to use humans to study 
the complexities of the disease, but 
unless researchers are willing and 
able to study cancer patients for de-
cades at a time, it’s just not feasible for 
diseases that typically develop later 
in life. Instead, researchers use mice 
as models for humans. “This is one 
of the biggest challenges when we 
use laboratory animals as surrogates 
for people,” Benninghoff said. “We 
all know a mouse is not a human. But 
we can optimize our studies the best 
that we can and make these models 
better.”
Optimizing animal models to study 
cancer risk is one aspect that makes 
this project unique. “Historically, when 
scientists have looked at cancer 
in mice, they feed these animals a 
healthy diet to get them to the optimal 
level of health,” Benninghoff said. “My 
colleagues and I looked at that prac-
tice and said, ‘Well, that really doesn’t 
emulate what Americans eat.’” Instead 
of following the traditional model, the 
research team developed a diet for 
rodents that more closely mimics what 
the average American is eating: a diet 
high in fats, high in simple sugars, and 
lacking many vitamins and minerals. 
After implementing the “Western 
diet” into their studies, Benninghoff’s 
team compared mice on a healthy diet 
to mice consuming the diet that re-
flects what Americans eat. Mice on the 
Western diet had a much higher rate 
for tumor development in the colon, 
which didn’t surprise Benninghoff and 
her colleagues. Their findings fit with 
other epidemiological research that 
points to poor diet being a huge risk 
factor for colon cancer. The next step 
for the research team is to figure out 
why this is the case. 
The team is examining the gut 
microbiome, which is the collection of 
microorganisms in our stomachs. The 
WHAT’S ON YOUR PLATE?
UAES Researcher
Examines Connections
Between Diet and
Cancer Risk
By Shelby Ruud
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human gut is host to an ecosystem of more than 100 trillion 
bacteria. This microbiome plays a big role in the body’s 
digestive system—it metabolizes indigestible compounds, it 
produces energy and it provides defense against pathogens. 
With the gut microbiome playing all these roles, it’s possi-
ble that protection against colon cancer may be dictated 
in part by the gut microbiota population. In fact, the gut 
microbiomes of patients with gut inflammation are noticeably 
different from healthy ones, with consistent observations 
of less diversity and richness of the microbial community. 
Understanding specific gut microbiome patterns that are 
associated with disease risk could provide new targets for 
risk reduction or therapy.
The role of micronutrients has also been a point of 
interest for the research team. Benninghoff said many people 
think of poor food choices and associate them with macronu-
trients like fats. Benninghoff’s work suggests that a lack of mi-
cronutrients, including vitamins and minerals, plays a much 
more substantial role in cell health and increased cancer risk. 
“The role of micronutrients was a bit of a surprise, based 
on what we’d previously thought,” Benninghoff said. “But 
when you look at how these micronutrients have a central role 
in maintaining proper cell functions, it’s not really a surprise 
at all.” Benninghoff’s team is now working on understanding 
which micronutrients play a key role in the long-term health of 
the intestine.
It’s not all bad news, however. Instead of focusing solely 
on factors that exacerbate diseases, the research team is 
also interested in foods that do the opposite and reduce the 
risk of cancer. Bioactives are chemicals naturally found in 
certain foods, but they’re not the standard vitamins and min-
erals. These chemicals can interact with our cells and pro-
mote health, prevent inflammation and block some pathways 
that might lead to cancer. The Applied Nutrition Research 
Group is studying bioactives in foods such as broccoli, green 
tea, tart cherries—even purple corn. 
Utah State University Associate Professor and Utah Agricultural Experiment Station researcher Abby Benninghoff.
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And the benefits of a colorful plate could have implications far into the future. 
Using the mouse models for their research, the team is examining ancestral expo-
sure to diet. They are interested in whether or not someone’s poor food choices 
could negatively affect the health of their offspring generations into the future. This 
field of research is called epigenetic inheritance and examines the epigenome, 
which is another layer of genetic code similar to the genome, and how it can be 
inherited across generations. The research team believes that this could be a key 
to understanding cancer risk. 
“People are already recommended to eat well,” Benninghoff said. “If we tell 
people that your children, or your grandchildren, or your great-grandchildren 
could suffer because of your diet choices, I think it could lend weight to the nutri-
tion recommendations that doctors give their patients.”
Benninghoff and other team members, including USU researchers Korry 
Hintze, Michael Lefevre, Robert Ward and Jeffery Broadbent and graduate 
student Sumira Phatak, are several years into this project and are beginning to 
accumulate the results of their various studies. Benninghoff said one of the most 
rewarding parts has been tabulating the data, examining the results and asking 
“What did we learn?”. The team is always considering where they can take this 
project next.
“When I was a graduate student, my biggest fear was that I’d run out of 
ideas,” Benninghoff said. “But it’s been the complete opposite. There’s so much I 
want to do in terms of research. The ideas are absolutely not in short supply.” ¤
AWARD WINNING
In 2015 and again in 
2016, Benninghoff and her 
collaborators, including USU 
toxicologist, Professor Roger 
Coulombe, won the Multi-
State Research Award from 
the Western Association 
of Agricultural Experiment 
Station Directors. This award 
recognizes excellence within 
a collaboration that includes 
representatives from several 
states across the nation. 
“The work that [these] 
researchers have conducted 
has increased our under-
standing of the complex 
relationship between bio-
active dietary chemicals 
and human health, which 
is of paramount concern 
to consumers, agricultural 
producers, food processors, 
health professionals, and 
policymakers charged with 
maintaining a safe and nu-
tritious food supply.”
The team includes re-
searchers from 18 other 
universities and government 
research agencies. 
“The best advice I can 
give for anyone who wants 
to reduce their cancer 
risk and improve their 
overall health is to make 
their plate as colorful as 
possible,” Benninghoff 
said. “A lot of foods that 
have the healthy bioactives 
are brightly colored, so 
look for the vibrant greens, 
blues and reds.”
Contact Info: 
Abby Benninghoff
Abby.Benninghoff@usu.edu 
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UNCOMMON 
HAMSTERS
HELPING
FIGHT
COMMON
VIRUSES
By Nancy Solomon & Lynnette Harris
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Using an animal model they developed, Utah State University and Saint Louis University researchers have identified a strategy that could 
keep a common group of viruses called adenoviruses 
from replicating and causing sickness in humans.
The study, published in the Aug. 20 issue of PLOS 
Pathogens, is the first to report use of a genetically 
modified Syrian hamster that may prove important in 
studying other dangerous viruses. 
“The adenovirus can cause colds and infections in 
the eyes and respiratory system and generally are not 
serious,” said William Wold, co-senior author of the paper 
and chair of molecular microbiology and immunology at 
Saint Louis University. “However, like many other viruses, 
adenovirus can replicate at will when a patient’s 
immune system is suppressed. Adenovirus 
can become very dangerous, such as for a child who is 
undergoing a bone marrow transplant to treat leukemia.”
Wold and his colleagues found that Type 1 interferon 
is critical to preventing adenovirus from multiplying. 
Interferon is a protein and part of the body’s immune 
response that fights against invading pathogens. Cells 
that are infected by a virus release interferon to signal 
nearby non-infected cells to be on alert to fight the 
invading virus.
Researchers led by Zhongde Wang, associate 
professor of veterinary diagnostics and infectious 
diseases in USU’s Department of Animal, Dairy and 
Veterinary Sciences and co-senior author of the paper, 
turned off the STAT2 gene in a group of Syrian hamsters, 
which disrupted the Type 1 interferon pathway by 
interrupting the cascade of cell signaling. The team 
compared that group with a group of wild-type control 
animals, both of which had adenovirus. The genetically 
modified Syrian hamsters had 100 to 1,000 times more 
virus in their bodies than the control.
“While thousands of papers have been published on 
the replication of adenovirus in a cell culture model, until 
now, not much has been understood about the molecular 
details during adenovirus replication in humans,” Wold 
said.
Wang said, “Besides providing an insight into 
adenovirus infection in humans, our results are also 
interesting from the perspective of the animal model: the 
STAT2 knockout Syrian hamster may also be an important 
animal model for studying other viral infections, including 
Ebola, hanta and dengue viruses.”
The animals used in the study with the STAT2 gene 
disrupted – or knocked out – are the first Syrian 
hamsters developed for gene-targeting.
“Due to their unique physiology, the 
Syrian hamster offers advantages over 
other rodent species in modeling human 
diseases,” Wang said. “But the application 
of hamsters as animal models suffered 
from the lack of genetic tools to engineer 
their genomes. The success we achieved 
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with gene-targeting in the Syrian hamster provides the 
opportunity to create genetically engineered hamsters 
as models for many of the human diseases for which 
there are either no existing animal models or models with 
severe limitations.”
Previously, Wold led a research team that identified 
the Syrian hamster as an appropriate animal model 
to study adenoviruses because human adenovirus 
replicates in these animals, causing sickness that is 
similar to that seen in humans. Wang said the work 
reported in PLOS 
Pathogens is significant 
because there was 
previously no animal 
model for studying 
adenovirus replication 
without using drugs 
to suppress animals’ 
immune systems. The 
study provides a basis 
for using the STAT2 
Knockout hamsters to 
understand infection 
and to develop antiviral 
drugs and vaccines.
In addition, 
Wang said, a variety 
of adenoviruses – 
known as oncolytic 
adenoviruses – 
preferentially infect 
and kill tumor cells 
are of great interest 
in treating human 
cancers, but none 
of the small animal 
models currently in use 
allows adenoviruses 
to replicate effectively. 
Because the newly 
developed hamsters do permit the virus to replicate, they 
open a door to new methods of developing and studying 
cancer-fighting adenoviruses.   
Other members of the research team include Karoly 
Toth, Baoling Ying, John E. Sagartz, Jacqueline F. 
Spencer and Ann E. Tollefson, Saint Louis University; 
Sang R. Lee and Wang, Utah State University; and 
Il-Keun Kong, Gyeongsang National University, Jinju, 
South Korea.
Wang’s research group made a technical 
breakthrough in 2013 with gene targeting in the golden 
Syrian hamster and produced the world’s first genetically 
engineered hamsters, in collaboration with Kong’s 
group in South Korea. The initial advancement was also 
supported by technical contributions from two other 
laboratories at USU led by Ken White, animal scientist 
and dean of the College of Agriculture and Applied 
Sciences, and Thomas Bunch, emeritus professor of 
animal science.
The paper is available on the PLOS Pathology 
website at:  http://journals.plos.org/plospathogens/
article?id=10.1371/journal.ppat.1005084 ¤
Contact Info: 
Zhongde Wang
Zonda.Wang@usu.edu 
Top Left: Associate Professor Zhongde Wang.
Bottom Left: Schematic of adenovirus: National Institutes of 
Health.
Above: Transmission electron micrograph (TEM) of adenovirus 
virions. Photo courtesy of CDC/ Dr. G. William Gary, Jr.
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When viruses cause disease and make local, national and international news, most of us react with some anxiety, take precautions to prevent or 
limit contact with the virus and adopt a heightened aware-
ness of symptoms. When Professor John Morrey and his 
colleagues at Utah State University’s Institute for Antiviral 
Research hear and read stories of dangerous emerging or 
recurring diseases, it’s rarely “news” to them, but it brings a 
renewed urgency to their work.
“When people ask ‘How’s your work going?’ I tend to 
always look ahead and think of the challenges and needs 
instead of looking back and seeing our successes, and we’ve 
had some great successes,” Morrey, the institute’s director, 
said. “There is always more to do. We always need more 
data, more ideas, and there are always more grants to write, 
more papers to write, more things to understand.”
Morrey can be forgiven for focusing on the challenges. 
When your work is studying viruses, you may experience 
some exciting breakthroughs, but you are never really 
finished.
The institute’s team includes seven lead investigators 
who are Department of Animal, Dairy and Veterinary Sciences 
faculty members, six PhD-level senior research associates, 
and several full-time and student technicians. The viruses 
and diseases they study—think influenza, hanta, dengue, 
West Nile, chikungunya, SARS and Zika—could comprise an 
international “Most Not Wanted” list. The researchers don’t 
discover new drugs, they test possible treatments in cell 
culture and animal models, investigate basic mechanisms of 
how viruses function and cause disease and search for ways 
to disrupt a viruses’ particular ability to do damage.
Doing basic biological research is important, but not filled 
with daily, flashy “Eureka” moments. However, without basic 
research the development of drugs, vaccines and tests for 
diseases would never happen. For example, the researchers’ 
discovery of the ways in which viruses like West Nile infect 
the brain stem and cause respiratory problems is important 
because it gives drug developers better targets for treatments 
and vaccines. Morrey likened it to being a guide.
“If you go fishing in a large lake you need to go where 
the fish are,” he said. “By discovering that West Nile and 
other neurological viruses can cause respiratory deficits, 
particularly with lesions in the spinal cord and brain stem, 
we’ve helped get scientists in the part of the lake where they 
can be productive.”
The team reached a notable milestone this year, 
surpassing $107 million in grants and contracts since the 
institute was founded in 1977 and led by Robert Sidwell, 
now an emeritus professor. But don’t go looking for them in 
a gleaming, high-profile research center. Most of their work 
goes on in secured laboratories with up-to-date equipment 
and protocols, but the modest surroundings belie the caliber 
of research that goes on there every day. 
To Morrey, surpassing the $100 million mark in grant 
funding represents the group’s collective work and “the many 
pharmaceuticals in which we have played a part, and seeing 
them used by people around the world to fight viral disease 
and improve lives.”
Science
vs.
Viruses
By Lynnette Harris
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VIRUSES IN THE LAB
Studying viruses in cell culture can tell scientists a great 
deal, but animal models play crucial roles in understanding 
viruses and testing possible treatments. Research Associate 
Professor Justin Julander explained that the complexity 
of the body, whether human, mouse or hamster, can’t be 
replicated in a petri dish or flask. Experiments in cell culture 
are important for targeting and measuring some responses, 
but cultures don’t replicate nearly countless variables like 
neuron function, respiration and immune response. Studies 
in animal models are important steps on the path to treating 
humans and running complex and expensive clinical trials 
of vaccines and drugs in humans. However, mice and 
hamsters are not naturally susceptible to virus strains that 
infect humans. 
Associate Research Professor Bart Tarbet pointed out 
that a key reason the researchers can do their work is the 
institute’s colony of mice with specific genes “knocked out” 
to make them receptive to virus infection. Colleagues at 
USU also recently developed a first-of-its-kind, genetically 
engineered hamster that is proving valuable in the search 
for Zika virus treatments. Tarbet’s lab works with genetically 
engineered mice in the search for a new model for 
treatments of enterovirus D68 (EV-D68). The virus is one 
among a family that includes polio and more than a 100 
non-polio viruses, and has caused illness that the Centers 
for Disease Control and Prevention has tracked since 1987. 
But in 2014, there was a spike in the number and severity of 
EV-D68 cases. Most troubling though was that some people 
developed a polio-like neurological disease, not just the 
usual respiratory infection that causes problems primarily 
for the very young, 
the very old and 
people with asthma. 
With funding from 
National Institutes of 
Health (NIH), Tarbet’s 
lab is focused on 
developing a reliable 
testing model, and 
will follow that with 2 
years of evaluating 
possible treatments.
It’s important to 
note that most drugs 
don’t make the cut 
from cell culture 
to tests in animal 
models and even 
fewer progress to 
clinical trials.
“For example, 
3 years ago the 
institute screened 
over 10,000 drugs to treat influenza in cell culture,” Tarbet 
said. “Of those, fewer than 2 percent showed activity against 
the virus and just those few were considered for testing in 
animal models.”
Left: Colorized transmission electron micrograph of avian influenza A H5N1 viruses (seen in gold) grown in 
MDCK cells (seen in green).  Photo Credit: Cynthia Goldsmith, Centers for Disease Control and Prevention
Right: This photo shows an electron micrograph of a thin section of EV-D68, showing the numerous, spherical 
viral particles. Image source: Cynthia S. Goldsmith and Yiting Zhang, CDC
Above: This is a transmission electron micrograph (TEM) of the West Nile virus (WNV). See PHIL 2290 for 
a black and white version of this image. Photo Credit: Cynthia Goldsmith, Centers for Disease Control and 
Prevention
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Contact Info: 
David Holzman
Paul.Jakus@usu.edu 
Top: Model of H1N1 Influenza virus.
Above: The illustration shows a viral membrane decorated 
with spike glycoproteins; highlighted in red is a potential 
neutralization site, which is a protein sequence that might be 
used as a target for vaccines to combat viruses such as MERS-
CoV and other coronaviruses. Photo Credit: David Veesler, 
University of Washington
Right: The core of the USU’s Institute for Antiviral Research 
are faculty members (left to right, front) Justin Julander, Dale 
Barnard, Craig Day, (center) Don Smee, John Morrey (back) 
Brian Gowan, Bart Tarbet.
Julander said 
because it costs 
millions of dollars 
to develop a new 
drug and bring it to 
market, the institute’s 
team feels fortunate 
to be doing work 
at the university 
where they are not 
tied to a company’s 
bottom line. Morrey 
added that some 
people believe that 
any scientist who 
associates with the 
pharmaceutical 
industry has been 
bought off. 
“The fact is, the 
data we generate 
is completely unbiased, and whether it’s good news or 
bad news for a particular treatment, they get whatever we 
learn,” Morrey said.
CHALLENGES: PAST AND PRESENT
Battling established and emerging virus diseases is 
a complicated task for many reasons, some due to the 
nature of the viruses themselves and some because of 
the actions of people and animals they affect.
“One of the things that makes viral infections so 
difficult to treat is that viruses rely on the host’s cells 
for growth,” Morrey said. “It is the biggest challenge in 
developing therapies. Viruses rely on the machinery of 
the cells they infect. That is not the case with bacterial 
infections because, with a couple of exceptions, bacteria 
live outside our cells. So some of the conceivable 
approaches to eliminating a virus also eliminates the 
host’s cell. Virologists like to do better than that and find 
very specific, unique viral processes that can be targeted 
so the cell is not harmed, but the virus is eliminated.”
Another vexing characteristic of viruses is their 
ability to mutate, adapting to new surroundings or drug 
challenges. This ability allows viruses to expand their 
ranges, cause infection in new ways and become less or 
more virulent. It also means that once researchers have 
characterized a virus and how it works, the virus may have 
already changed. When viruses change in ways that make 
them more virulent or easier to transmit, the results can be 
devastating.
Such was the case with Spanish flu in 1918-1919. 
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That strain of influenza—a subtype of avian 
influenza H1N1—became more deadly 
and easier to spread, explained Research 
Professor Dale Barnard. As a result, 
20-40 million people died in a worldwide 
pandemic, far more than the 17 million who 
were killed in combat in that final year of 
World War I.
“Sometimes research can be driven 
by fear and media attention,” Barnard said. 
“But the experience of Spanish flu is one 
reason we are so vigilant and put great 
effort into understanding newly emerging 
viruses. We want to be able to intervene 
before something like that happens again.”
Another public health challenge is 
that people are very mobile today and 
can transport viruses to new locales with 
greater speed. Barnard said that prior to 
the mid-20th century the geographic range 
of two viruses he studies, Severe Acute 
Respiratory Syndrome (SARS) and Middle 
East Respiratory Syndrome (MERS), would 
have been quite limited. But today planes 
transport passengers and viruses between 
countries and regions of the world in a 
matter of hours.
Barnard and his team are at work 
screening antiviral drugs for effectiveness 
against MERS, coronavirus infections and 
respiratory syncytial virus (RSV) among 
other respiratory viruses. He observed that 
there are tools for drug development and 
testing that make the work faster than it 
was at the start of his career, but drug discovery hasn’t accelerated as rapidly as viruses’ abilities to spread.
Changing climate presents another challenge. Many virus-caused diseases are zoonotic, meaning they arise 
in animals and spread to humans. Mammals, birds and insects, like the now-famous, Zika-carrying Aedes aegypti 
mosquito, act as vectors for spreading viruses. Their ranges may expand or at least change as the climate and their 
habitats change.
 
ZIKA VIRUS IN THE NEWS
By the time stories about Zika virus hit mainstream media in the U.S. this spring, the Institute for Antiviral Research 
had already been at work with the virus for several months with funding from the NIH. The team of researchers has 
since demonstrated in mice and hamsters that the virus does transfer from mother to fetus and cause growth restriction 
and other developmental anomalies at various times during fetal development. That gives the team good models for 
studies, including evaluation of a possible vaccine and use of therapeutic antibodies that may stimulate the immune 
system to attack the virus.
Julander, who leads the institute’s Zika virus research, said they have seen size differences and ocular deformities 
in mouse pups born to dams that were infected with Zika virus. It appears that infection during the first trimester of 
pregnancy is the most troubling.
“We previously found with West Nile virus that infection in the first trimester is the most critical time for abnormal 
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fetal development and we see the same thing with 
Zika,” Julander said. “We need a vaccine to protect 
against Zika virus because more than 80 percent 
of people who get the virus have no symptoms or 
develop only a mild illness. The key to fighting most 
viral infections is starting treatment when the viral 
load is small. No one is going to go to the doctor 
because they got a mosquito bite, so by the time 
someone feels symptoms the virus has become well 
established.”
Though both West Nile and Zika virus are 
spread by mosquitoes and can cause neurological 
disease, Morrey said there are key differences 
between two. Zika virus can be spread from one 
infected person to other people via mosquito bites. 
It can also be sexually transmitted. West Nile does 
not spread in those ways.
“Zika can mutate, and it does” Morrey said. 
“It’s very interesting because you can get a blood 
sample, but can’t culture it by some of the expected 
cell culture techniques because its genes have 
already changed in the time it took for viremia to 
occur (the virus to develop in the bloodstream). 
The viruses actually change when they go from 
mosquito to human and from human to mosquito, 
but Zika does this in a more obvious way.”    
 
WHAT’S NEXT?
The faculty members at the core of the 
institute’s research team have “self-selected” to 
focus on specific kinds of virus infections. But the 
relatively small size of the team means ideas easily 
cross-pollinate, and discussions in lab meetings or 
in the hallway may lead to new questions, answers 
and shared expertise. There is no shortage of 
known viruses on which to focus so the research 
leaders, technicians and students go on working, 
networked with the larger scientific community, and 
always watching for signs that a new virus may be 
emerging, or a well-known one resurging.
Morrey said one frustration is that the 
procedure for approving new drugs does not 
currently work well for fighting emerging diseases. 
Regulations require that clinical trials include large 
numbers of people. The problem is that cases 
of people infected with an emerging disease are 
often sporadic and geographically far apart, so it is 
extremely difficult or impossible to include enough 
people in a single treatment trial.
“It has prevented the development of some 
drugs that could be useful, but the FDA is bound 
by law,” Morrey said. “The law needs to be adapted 
for emerging diseases like Zika and West Nile virus. It will 
require the political will to make those changes. It may require 
loosening some standards in order to accomplish the studies, 
and no one wants to be blamed for doing something that 
might not be safe.” ¤
Top: This is a digitally-colorized transmission electron micrograph 
(TEM) of Zika virus, which is a member of the family Flaviviridae. 
Virus particles, here colored red, are 40 nm in diameter, with an outer 
envelope, and an inner dense core. Image courtesy of CDC/ Cynthia 
Goldsmith.
Bottom: Human neural progenitor cells (gray) infected with Zika 
virus (green) increased the enzyme caspase-3 (red), suggesting 
increased cell death. Credit: Sarah C. Ogden, Florida State University, 
Tallahassee
Contact Info: 
John Morrey, John.Morrey@usu.edu 
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Reported active Zika virus transmission
No reported active Zika virus transmission
Countries & 
Territories 
with Active 
Zika Virus 
Transmission
Brazil
Venezuela
Colombia
Ecuador
Peru
Bolivia
Paraguay
Argentina
Guyana
Suriname
French Guiana
United States
Mexico
Nicaragua
Panama
Costa Rica
Honduras
El Salvador
Belize
Guatemala
*Data from Centers for Disease Control and Prevention
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States and Territories Reporting Zika 
Virus Disease
Solid shading represents travel-associated cases only
0
1 - 7
8 - 10
11 - 17
18 - 50
> 50
Widespread local vector-borne transmission
Limited local vector-borne transmission
Zika Cases Reported in the 
United States
US Virgin Islands
Puerto Rico
American Samoa
CNMI
Guam
TX
NM
FL
IL IN
OK
MO
IA
OH
PA
MN
WI
MI
KY
VA
NC
SC
WV
TN
GAALMS
AR
LA
KS
CO
NE
ME
NH
VT
NY
AZ
UT
WY
NV
CA
WA
OR
ID
MT
SD
ND
AK
HI
MA
RI
CT
NJ
MD
DE
*Data from Centers for Disease Control and Prevention
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Mapping
Zika
Virus
Genomes
A team of researchers at Utah State University has characterized the consensus genome sequences of three historically important Zika virus strains, 
an important step toward developing antiviral therapeu-
tic and preventive strategies against Zika, and related 
viruses. The research is published August 18 in Genome 
Announcements, a journal of the American Society for 
Microbiology.
“The epidemic in the Americas is potentially 
threatening the entire world,” said senior author Young-
Min Lee, associate professor in the College of Agriculture 
and Applied Sciences’ Department of Animal, Dairy and 
Veterinary Sciences. The new research, he said, may 
ultimately lead to stopping Zika’s spread, and preventing 
future outbreaks. 
Previously, these researchers focused on 
understanding the molecular basis of viral replication and 
pathogenesis of the Japanese encephalitis virus (JEV), a 
mostly neglected but clinically important pathogen, which, 
like Zika, is a flavivirus. That research has provided a lot of 
information that will be critical to efforts to tame Zika, said 
Lee. 
BY DAVID HOLZMAN
& LYNNETTE HARRIS
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For example, the researchers had sequenced several 
clinically important strains of JEV, and had developed a 
“reverse genetics” system for manipulating those viruses. 
That system made it possible to create recombinant 
and mutant JEVs. That, and other tools these 
investigators developed for JEV can easily be 
adapted to use on Zika. 
These tools will allow them to create an 
attenuated (less virulent) Zika virus that can 
serve as a candidate vaccine, said Lee. 
The researchers can attenuate the virus 
by inactivating a protein that Zika uses to 
invade human cells.  
The first of the three Zika virus strains 
whose sequences the researchers have 
characterized was isolated in 1947, from 
a sentinel rhesus monkey in Uganda. “A 
sentinel animal is an animal intentionally 
placed in a particular environment to detect 
the presence of an infectious agent in the 
area,” said Lee. “Zika virus was discovered 
accidentally in the Zika forest of Uganda during 
a search for yellow fever virus, another flavivirus 
related to Zika.” 
The second strain of Zika was isolated in 1966, 
USU scientists successfully sequenced the genomes of three important strains of Zika virus that will be important tools in the search 
for treatments and a vaccine against the virus. Back row, left to right: Sang-Im Yun, Jordan Frank, Young-Min Lee, Irina Polejaeva 
and Byung-Hak Song. Front row: Chris Davies, Ken White and Justin Julander.
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Left: Representation of Zika virus. Image courtesy 
of Kuhn and Rossmann research groups, Purdue 
University.
Above: This photomicrograph revealed some of the 
histopathologic changes in this specimen of equine 
brain tissue revealing the perivascular inflammation 
associated with this West Nile virus (WNV) infection. 
CDC/ A. Wilson; Brian W.J. Mahy, BSc, MA, PhD, 
ScD, DSc
TOP 5 THINGS
EVERYONE NEEDS TO  
 KNOW ABOUT 
 ZIKA
1 Zika primarily spreads through  infected mosquitoes. You can  also get Zika through sex.
Many areas in the United States have the type  
of mosquitoes that can spread Zika virus.  
These mosquitoes are aggressive daytime biters  
and can also bite at night. Also, Zika can be  
passed through sex from a person who has Zika  
to his or her sex partners. 
 
 
Repellent2
The best way to prevent Zika is  
to prevent mosquito bites.
          •  Use insect repellent. It works!  
          •  Wear long-sleeved shirts and long pants.  
          •  Stay in places with air conditioning or  
              window and door screens.  
          •  Remove standing water around your home.
3 Zika is linked to birth defects.Zika infection during pregnancy can cause a  
serious birth defect called microcephaly that is a  
sign of incomplete brain development. If you have  
a partner who lives in or has traveled to an area  
with Zika, do not have sex, or use condoms every  
time you have sex during your pregnancy.
 
4 Pregnant women should not  travel to areas with Zika.
If you must travel to one of these areas,  
talk to your healthcare provider first and 
strictly followsteps to prevent mosquito  
bites during your trip.
 
5 Returning travelers infected with  Zika can spread the virus through mosquito bites.
If you get infected with Zika and a mosquito bites  
you, you can pass the virus to the mosquito.  
The infected mosquito bites other people, who get  
infected. Returning travelers should also use  
condoms or not have sex if they are concerned  
about passing it to their partners through sex. 
WWW.CDC.GOV/ZIKA
CS264222-A August 2, 2016
from a pool of Aedes aegypti mosquitos 
in Malaysia. The third strain is responsible 
for the epidemic that recently swept Latin 
America. It was first isolated in early 2015, in 
Puerto Rico, and has now reached Florida, 
where it has begun to spread. 
From this research, and from an analysis 
using the sequences of 29 available Zika 
virus genomes, the Utah team has shown 
that these viruses fall into two major genetic 
lineages: One African and one Asian. The 
latter includes both the Malaysian, and the 
American epidemic strain. That latter strain is 
derived from an ancestor of the Asian lineage. 
Meanwhile, questions remain as to 
why the strains differentiated. Viruses face 
different environments in different hosts, 
said Lee. “The most obvious and significant 
challenge to the virus is the host immune 
response, and evasion of the host immune 
response is a key feature of the survival 
strategy. Studies are currently underway 
at Utah State University to examine the 
functional importance of the genetic variation 
on viral replication and pathogenesis.”
Other contributors to the genome 
sequencing project and co-authors on the 
paper are technicians and faculty members 
in the College of Agriculture and Applied 
Sciences: Sang-Im Yun, Byung-Hak Song, 
Jordan Frank, Justin Julander, Irina Polejaeva, 
Christopher Davies and Kenneth White. ¤
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Scientists at Utah State University have been record-ing and reporting daily weather observations for 125 years and the Utah Climate Center was recognized 
by the National Weather Service with an Honored Institution 
Award for that consistent service and the vast amount of 
data it has generated.
Accurate weather forecasts are crucial to decisions that 
affect people, corporations, government entities and entire 
economies, and those forecasts are built on records of daily 
weather observations. Each time Utah Climate Center staffers 
gather information about specific details of the day’s weather 
they are adding more important data points to an unusually 
long record. 
“Long records are very important to helping us 
understand climate and how things have changed over time,” 
said Randy Graham, meteorologist-in-charge at the National 
Weather Services’ Salt Lake City office. “Back in the day, this 
was about climatology and establishing our climate record. 
Now this data is going into numerical weather prediction 
models and helps improve our forecasts.”
Currently, daily observations are made and recorded 
by Utah Climate Center employees Martin Schroeder or 
Boniface Fasu, and occasionally by center director and State 
Climatologist Robert Gillies. Their work is added to records 
that include more than 45,600 days-worth of observations. 
Fasu explained that each day they record daily maximum and 
minimum air temperatures, precipitation, soil temperatures at 
four different depths and a description of visibility distances 
and note whether it’s sunny, overcast, windy, raining or 
snowing. In fact, one of the challenges in documenting the 
weather is the weather.
“Reading instruments in a blizzard is really interesting,” 
Gillies said. “And once, when a strong inversion had built for 
several days, I drove past the entrance to one station twice 
because I couldn’t see where to turn off the road.”
Lisa Verzella, a National Weather Service meteorologist 
who coordinates the network of Utah’s volunteer observers, 
UTAH CLIMATE CENTER HONORED
FOR 125 YEARS OF WEATHER DATA By Lynnette Harris
For more than 30 years Layne Coppock has led high-ly successful research programs that also change peoples’ lives in southern Ethiopia and northern Ken-
ya. His efforts were honored with two prestigious awards, 
one for career achievement in eastern Africa from a 
professional organization in Ethiopia, and another from the 
Board for International Food and Agricultural Development 
(BIFAD), recognizing the sustained success of a pastoral 
women’s collective-action project initiated in 1999. The 
work with the pastoral women was part of the USAID-fund-
ed Pastoral Risk Management (PARIMA) project at USU 
from 1997 to 2009.     
Coppock, a professor in the Department of Environment 
and Society and a Utah Agricultural Experiment Station 
researcher, received the 2015 Scientific Award for 
Excellence from BIFAD, is a presidentially appointed board 
that advises the United States Agency for International 
Development (USAID) concerning links between USAID and 
U.S. universities. 
The project was novel in that the focus was on a 
PROFESSOR HONORED FOR IMPROVING LIVES IN AFRICA
By Shelby Ruud & Lynnette Harris
synthesis:  Science at Utah State
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participatory, action-research approach 
where members of pastoral communities 
helped co-direct the work. A blend of 
research, outreach, informal education, 
and training led thousands of pastoralists—
mostly poor, illiterate women—to empower 
themselves and form self-help groups that 
saved money, invested wisely in a variety of 
economic development activities, improved 
risk management in their households 
level, and thus helped transform destitute 
communities.
“The key to success was building 
human, social, and financial capital—not 
the implementation of new production 
said although there are stations with automated sensors, 
people provide better records because they are familiar 
with the instruments they use and how they read them. In 
addition, when a severe weather event occurs and road 
crews and others need to know about current conditions, 
automated instruments may not “see” the activity because 
radar is blocked by mountains.
“But we can contact observers in an area and get a 
report of what’s really happening on the ground,” Verzella 
said. “We often get calls from insurance companies checking 
on weather events on a specific date when they are 
evaluating claims.”
Graham said data collected by observers is examined 
closely after a severe weather event, including information 
from the days and hours preceding it, to help develop better 
forecasting tools. Although individuals may think of weather 
only in terms of how it affects their plans, forecasting is vital 
to the nation’s economy. ¤
Collegues Getachew Gabru and Layne Coppock.
Utah Climate Center Director Robert Gillies with Randy Graham and Lisa Verzella from the National Weather Service’s Salt Lake City office, 
and climate center staffers Martin Schroeder and Boniface Fasu (left to right). 
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technology,” Coppock said. “Because the interventions are self-sustaining and easily replicated, the impacts from this project 
have grown over time.”
In 2003 there were 2,300 founding members in 59 groups with a savings and loan volume equal to U.S. $650,000. By 
2015–6 years after the project formally ended–there are 87,000 participants in 795 groups with a savings and loan volume 
over U.S. $28 million.
The work of Coppock and his team of Ethiopian and Kenyan colleagues is the first instance of rangeland-focused work 
being recognized by BIFAD. Members of the team include Coppock, Getachew Gebru, Solomon Desta, Seyoum Tezera,  
Azeb Yonas,  Abdillahi Aboud,  Mark Mutinda, and Stellamaris Muthoka. 
Coppock was also honored with a career achievement award from the Ethiopian Society of Animal Production. His 
career in East Africa has included his role in the National Science Foundation-funded South Turkana Ecosystem Project 
(Kenya) in the 1980s, authorship of a book on Ethiopian rangelands in the mid-1990s, stewardship of the PARIMA project, 
and his role in Ethiopian land-management research since 2012. After receiving his award, Coppock gave a presentation 
concerning interactions in Ethiopian pastoral systems that connect livestock production, human health and water quality.    
DeeVon Bailey, associate dean for research in the College of Agriculture and Applied Sciences, who formerly oversaw 
international program development at USU, said Coppock is successful because he works with people at the grassroots level 
and asks them what they believe would help their situation the most. Then the research, outreach, and training aspects are 
packaged around those goals.   
“I consider his programs, especially the PARIMA pastoral women’s program, to be the most successful U.S. university-
implemented program I have seen during the almost 20 years I have been working in Africa,” Bailey said. “Layne has 
discovered the key that marginalized, uneducated people are trapped by poverty. They are very talented and thus capable 
of solving many of their own problems, but they need to be empowered to do so. Empowerment comes from respecting their 
wisdom, providing guidance, and helping them gain access to the appropriate tools and techniques. Such success does not 
come from top-down research initiatives.”  ¤ 
Participants in the Pastoral Risk Management project women’s program learned new animal management and business skills that improved 
rangeland ecology and their families’ economic well-being.
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Chris Davies, research associate professor in the Department of Animal, Dairy and Veteri-nary Sciences, was recently named associate 
director of the Utah Agricultural Experiment Station.
Davies received both his Doctor of Veterinary 
Medicine and PhD from Cornell University. Before 
joining Utah State University in 2007, he was a 
researcher and associate professor at Washington State 
University.
Davies’ strong background in animal science 
research and work with USU’s Center for Integrated 
BioSysems have prepared him for the new position. 
While working on his undergraduate and graduate 
degrees he trained horses, worked at the Cornell 
Dairy and became interested in immunology, which, 
ultimately led to his career in studying immunogenetics. 
His research at USU focuses on immune response 
and gene expression at the maternal-fetal interface, 
specifically in cattle. Davies is excited to use his 
research background to further the mission of the Utah 
Agricultural Experiment Station.
“Utah State University has a strong agricultural 
research program,” Davies said. “We are one of the 
top Ag schools in the country and I want to continue to 
build on that success.  Part of that is overseeing use 
of money to strengthen programs and provide core 
resources for our faculty who conduct research. Many 
people don’t know that although most experiment 
station researchers are in the College of Agriculture 
and Applied Sciences, we also support projects in the 
university’s colleges of science, natural resources, 
education and human services, engineering and in 
humanities and social sciences.”
Davies is assuming the position formerly held by 
long-time UAES Associate Director Donald Snyder who 
retired in June. Davies will work to support the Utah 
Agricultural Experiment Stations mission of generating 
knowledge and new technology to “improve the diverse 
system of agriculture and natural resources that feeds, 
clothes, houses and enhances the environment for 
Utah’s citizens.” His primary responsibility will be to 
manage research funding from the State of Utah and 
U.S. Department of Agriculture to ensure that it is used 
and reported on appropriately. ¤
EXPERIMENT STATION 
GETS NEW ASSOCIATE 
DIRECTOR
For 10 weeks last summer, nine students from small colleges in Utah 
and surrounding states worked in research laboratories with USU faculty 
mentors in the Summer Undergraduate Agricultural Biotechnology Research 
Experience (SURE). “I think the connections and the experiences that come 
from this unique program have a lot of potential to change students’ career 
objectives and opportunities,” said Chris Davies, the program’s co-director. 
Students received a stipend for their work improving crop varieties, 
developing biofuels, studying antiviral drugs and exploring other agricultural 
and biological problems.
Jackie Bedoya-Wilkinson, a student at Weber State University said, “I never 
thought I would be able to participate in undergraduate research. I didn’t 
even know how to get started. Now I get to use state-of-the-art equipment 
to work on important projects every day.”
Davies said the SURE program is set to continue for at least the next 2 
years with funding from the USDA.
By KailCee Harrison
Research Associate Professor Chris Davies.
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There is an eye-catching photo of a fat mouse and a thin mouse on the flyer soliciting participants for a campus research project. You might conclude 
that this study is related to diet and exercise, but it isn’t. 
Both mice were fed the same diet; the only variable is 
the bacteria in their gut. Korry Hintze, a Utah Agricultural 
Experiment Station researcher and associate professor 
in Utah State University’s Department of Nutrition, Dietet-
ics and Food Sciences, is studying how this could be 
applied to human health.
“Gut bacteria, or microbiome, has co-evolved along 
with humans and animals, Hintze said. “Only recently 
have we been able to understand many of the ways it 
relates to health. The field exploded because of DNA 
sequencing. It is an easier and cheaper way to examine 
bacteria than the old methods of bacteria culturing, and 
some bacteria could not be cultured. “
There was a time when we thought all bacteria were 
harmful and that using antibiotics to kill them would lead 
to better health, Hintze said. But there are as many as 
1,000 species of microorganisms in the human digestive 
tract, and more recently, scientists are discovering how 
useful and variable the microbiome is. For instance, 
Cesarean-delivered babies have a different microbiome 
than those born vaginally. This is because babies are 
born pretty much sterile and acquire bacteria from their 
mothers at delivery. So babies delivered via C-section 
have a microbiome more analogous to their mother’s skin 
as opposed to the mother’s natural gut microbiome. 
We also now know that breast feeding plays an 
important role in both the health of the baby and the 
OUR COMPLICATED 
RELATIONSHIP 
WITH THE
MICROBIOME
By Dennis Hinkamp
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microbiome, Hintze said. Breast 
milk contains indigestible milk 
fiber. Because species don’t 
generally develop wasteful 
adaptations, researchers 
conclude that a large part of 
breast milk is not there for the 
baby; it’s there for the newly 
emerging bacteria in the baby’s 
gut.
Microbiome variability is a 
proven factor in mouse weight gain. 
Counterintuitively, the more efficient the 
bacteria, the greater chance of obesity. Is 
swapping microbiomes a cure for obesity?
By Dennis Hinkamp
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The “Fecal 
Microbiota Transplant 
Study” is designed to 
answer some of these 
questions, Hintze said. The 
Center for Human Nutrition 
Studies will collect fecal 
samples from lean and obese 
volunteers. The samples will 
be homogenized in a saline 
solution and transferred to 
the mice through a feeding 
tube. The mice will then be 
fed low and high calorie 
diets and monitored to see 
if the human microbiome 
affects their weight gain. 
Their health, weight and body 
composition will be examined 
Mice and humans consume food 
that may not be digestible to them 
but is digestible to the microbiome, 
Hintze said. More efficient gut bacteria 
can convert more of that food to 
short-chain fatty acids which can be 
absorbed as added calories. The less 
efficient bacteria let undigested food 
pass through as waste. 
“It’s well 
known that obese mice 
have microbiomes that are more 
efficient at making this conversion 
and returning energy to the host,” 
Hintze said. “There are, however, 
a lot of unknowns about how this 
would work in humans. We are 
not as reliant on short chain fatty 
acids. Mice have a fermentation 
pouch in their digestive system that aids 
digestion and we don’t.”
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to see if the human microbiome characteristics are 
transferred to the mice.   
“This used to be an extremely expensive process 
because of the difficulty of raising research mice that 
were bacteria-free,” Hintze said. “We have found 
a quicker, less expensive way of starting the mice 
off bacteria free. We treat them with antibiotics for 2 
weeks prior to the transfers.” 
Human to human fecal transplants show promise 
but doctors are proceeding with caution, he said. 
Microbiome transplants from healthy humans to those 
infected with clostridium difficile colitis “c-diff” have 
been 98 percent effective at curing the sometimes 
deadly bacterial infection that can develop in people, 
usually in care facilities, who have had long-term 
antibiotic treatment. Because antibiotics destroy 
many of the microorganisms that normally keep c-diff 
bacteria in check, it can grow without competition 
and release toxins that attack the intestinal lining and 
can cause life-threatening holes in the intestines or 
inflammation in the colon. 
We shouldn’t have to say this, but “don’t try this 
at home,” said Janet Bergeson, clinical coordinator at 
Left: Undergraduate researchers Niklas Aardema and Ashli Hunter working with mice in the lab.
Above: Human nutrition researchers Korry Hintze, Daphne Rodriguez and Janet Bergeson.
Contact Info: 
Korry Hintze
Korry.Hintze@usu.edu 
USU’s Center for Human Nutrition Studies. If you search 
the Internet you will find tutorials on concocting fecal 
transfer home remedies. The danger is that you don’t 
know what microbiome traits you might be transferring. 
Certain microbiome characteristics are also associated 
with diabetes and colon cancer.
Hintze said “probiotics” available as supplements 
are generally regarded as safe, but there isn’t much 
good research to support the claims that they are 
effective. If they do work, you must consume them 
regularly because they don’t survive well in the gut.  
Studying the microbiome brings into question 
exactly what we are. There’s “us” and also the symbiotic 
bacteria that live inside us. Hintze said we need to look 
at ourselves as more of a superorganism rather than us 
and them. For the health of the superorganism we need 
to consider the effects of foods and medicines not just on 
us, but also on the microbiome that coexists with us. ¤
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TRANSGENIC 
GOATS
MAY
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HEAL 
HEARTS
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Scientists from Utah State University and the University of Utah have developed a new animal model to better understand atrial fibrilla-tion, the most common type of heart arrhythmia. 
Irena Polejaeva in USU’s College of Agriculture and Applied 
Sciences, and Ravi Ranjan, from the U of U School of Medicine, lead a 
team of researchers that have created the first transgenic goat model for 
atrial fibrillation. Their findings were recently published in the Journal of 
Cardiovascular Electrophysiology. 
 According to Polejaeva, associate professor in USU’s Department 
of Animal, Dairy and Veterinary Sciences, there are typically two types of 
models used in cardiology: transgenic mouse models commonly used to 
understand gene function, and large animal models including pigs, goats 
and dogs that are not genetically modified.  
“What we’ve done is combine these two approaches,” Polejaeva said. 
“We produced a transgenic large animal model, which makes several 
conditions much more reproducible because it is similar to a human-sized 
heart.”
Now the researchers are studying the relationship between atrial 
fibrillation and cardiac fibrosis, the formation of excess fibrous connective 
tissue in the heart that lowers its functionality. This condition is commonly 
associated with atrial fibrillation, though the exact relationship is unclear. 
Polejaeva said with atrial fibrillation affecting upwards of 2.7 million 
adults in America and causing an irregular, rapid heartbeat and leading to 
fainting, chest pain, stroke, heart failure and other health problems, there 
was a need for a more effective way to study these heart conditions. 
“This goat model, that closely and uniquely resembles the human 
disease, provides a unique platform to study and gain a mechanistic 
understanding of how fibrosis makes these hearts more susceptible to atrial 
fibrillation,” said Ranjan, doctor and associate professor in the Division of 
Cardiovascular Medicine and clinical electro physiologist at the U of U.
According to Ranjan, this model will play a key role in developing new 
drugs, examining device-related treatments, and identifying the best timing 
and duration of preventative treatments.  
The Utah Science Technology and Research Initiative (USTAR), the 
Utah Agricultural Experiment Station and the American Heart Association 
currently fund the project.  
Other researchers involved in the successful collaboration and co-
authors on the report are: Christopher Davies, Misha Regouski, Justin Hall, 
Aaron Olsen, Quinggang Meng, Heloisa Rutigliano, Aaron Thomas, Rusty 
Stott, Kip Panter Arnaud VanWettere, John Stevens, Zhongde Wang and 
Kenneth White at Utah State University; Derek Dosdall, Nathan Angel, 
Frank Sachse, Thomas Seidel, Rob Macleod and Nassir Marrouche at the 
University of Utah; Pamela Lee, Washington State University College of 
Veterinary Medicine.  
Contact Info: 
Irina Polejaeva, Irina.Polejaeva@usu.edu 
Left: USU Associate Professor Irena Polejaeva.
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From 2010 to 2015, Utah State University’s Institute for Antiviral Research and Center for Integrated BioSystems trained personnel from vaccine manu-
facturers in developing countries in support of the World 
Health Organization’s international vaccine production 
capacity building program. Through that involvement I 
became interested in global public health, and teaching 
microbiology and infectious diseases in the new School 
of Veterinary Medicine has expanded my interest to 
global animal health. I have heard it said that we are all 
part of a “global village”.  In our modern world infectious 
diseases can travel remarkably fast.  
Over the last 30 years, approximately 75% of new 
and emerging human diseases have been zoonotic 
(meaning a disease transmitted from animals to people), 
and many have come from wildlife.1  The Foresight Report 
describes the projected risks from infectious diseases 
of humans, animals and plants over 10- and 25-year 
horizons, and predicts that the highest probability of 
ONE HEALTH
AND EMERGING
INFECTIOUS 
DISEASES
By E. Bart Tarbet, Research Associate Professor
Department of Animal, Dairy and Veterinary Sciences
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emergence will be associated with RNA viruses, especially those found at the 
human-animal interface.2  Understanding the mechanisms that underlie newly 
emerging and reemerging infectious diseases is one of the most difficult scientific 
problems facing society today. Examples of human disease outbreaks that had 
their initial transmission from animals include: avian influenza in 1997, Severe 
Acute Respiratory Syndrome (SARS) in 2003, the novel swine-origin H1N1 strain of 
influenza A virus in 2009, and Middle East respiratory syndrome (MERS) in 2012.
It is critical for the future control of disease outbreaks to understand and 
respond appropriately to new and emerging disease threats. This will require 
a paradigm shift from outbreak response, to predicting the outbreak before it 
happens. One such approach involves One Health, the emerging discipline that 
brings together human, animal and environmental health.  The first Utah One 
Health Symposium was held in October 2015, and members of the USU School 
of Veterinary Medicine played an important role in the success of that event. 
Another symposium on this new and important topic is set for October 2016.
The essence of One Health is a collaborative, integrated, and 
multidisciplinary approach to better understand and better address the 
challenges and threats of infectious diseases to humans and animals. This 
approach will require infectious disease experts, physicians, veterinarians 
and environmental scientists to collaborate and identify the underlying 
drivers of disease emergence and develop interventions that prevent the 
transmission of disease. We need to understand the conditions that allow 
diseases to emerge and spread due to increased population density in cities, 
increased use of intensive farming practices, and increased travel globally. 
In addition, we must learn from recent experiences, and move from a crisis-
driven society to one of prevention and preparedness.
One Health as a concept embraces disease ecology, and contributes to a better understanding of emerging 
disease dynamics and the interdependence between human, animal and environmental health in addressing 
emerging disease threats. ¤
___________________________
Bart Tarbet began his training in infectious diseases (medical microbiology) at the Louisiana State University Medical 
Center in 1992.  He worked for 12 years in the vaccine industry and developed veterinary vaccines to emerging (West 
Nile Virus) and reemerging (influenza virus) diseases in multiple species of animals. At the USU Institute for Antiviral 
Research, his research in human and animal infectious diseases has merged into developing animal models of human 
infectious disease for evaluation of experimental therapeutics and vaccines. 
References
1 Taylor, L.H., Latham, S.M., Woolhouse, M.E. (2001) Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci. 
356:983-9.
2 Brownlie, J., Peckham, C., Waage, J., Woolhoose, M., Lyall, C., Meagher, L., Tait, J., Baylis, M., Nicoll, A. (2006) Foresight. Infectious 
Diseases: Preparing for the Future. Future Threats. Office of Science and Innovation, London, United Kingdom.
Research Associate Professor Bart Tarbet.
Contact Info: Bart Tarbet, Bart.Tarbet@usu.edu 
ON THE BACK COVER
3D computer-generated image of a group of methicillin-resistant 
Staphylococcus aureus (MRSA) bacteria. U.S. Centers for 
Disease Control and Prevention - Medical Illustrator.
30   Utah Science
Utah Agricultural Experiment Station
4845 Old Main Hill
Logan, UT 84322–4845 
Nonprofit Org.
U.S. Postage
PAID
Permit 1
Logan, Utah
